Author: Adam Marcus

Retraction cites “unintended excessive reuse” in commentary — of paper it was praising

rejuvreschcoverWe here at Retraction Watch HQ are always on the lookout for euphemisms for plagiarism (and other misconduct, of course). Among our favorites are “referencing failure” and the journal that allowed researchers to call plagiarism an “approach” to writing.

Here’s a new one that’s sure to do well with voters.

The journal Rejuvenation Research has retracted a commentary for, well, containing too much of the very text it was supposed to be commenting on.

The editorial was by Giorgio Aicardi, of the University of Bologna, in Italy, and the article Aicardi was writing about was titled “Synaptic distributions of GluA2 and PKMζ in the monkey dentate gyrus and their relationships with aging and memory.” That article had been published in the Journal of Neuroscience last year by a group from Mount Sinai in New York.

We’ll let the notice do the explaining: Continue reading Retraction cites “unintended excessive reuse” in commentary — of paper it was praising

Updated: Integrity “uncertain,” journal retracts stroke paper

emmcover

Experimental & Molecular Medicine has retracted a 2012 paper on stroke by a group of South Korean researchers after learning that one of the figures in the article was unreliable.

The article was titled “Protective effects of transduced Tat-DJ-1 protein against oxidative stress and ischemic brain injury,” and it came from a team at Hallym University in Chunchon.

According to the retraction notice: Continue reading Updated: Integrity “uncertain,” journal retracts stroke paper

Duplicate submission costs authors two papers on Parkinson’s disease

neuropeptidecoverA group of pharmacology researchers in the UK has lost two papers after submitting effectively identical versions to different journals — and getting them accepted, of course — just a day apart.

The first article appeared on the British Journal of Pharmacology‘s website on July 10, 2012. It was titled “Exendin-4 reverts behavioural and neurochemicaldysfunction in a pre-motor rodent model of Parkinson’s disease with noradrenergic deficit.”

Paper 2 appeared in the journal Neuropeptides in October, although it has an online pub date of August 24, and was titled “Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson’s disease with combined noradrenergic and serotonergic lesions.”

Continue reading Duplicate submission costs authors two papers on Parkinson’s disease

Amid a legal dispute, journal downgrades a retraction to an expression of concern

cellcyclecoverThe journal Cell Cycle is expressing a “note” of concern about a 2012 paper by a former researcher at the University of Minnesota, who has claimed that her mentor at the institution was violating her copyright. It turns out the journal had briefly retracted the paper, but reversed itself with the expression of concern — a curious about-face that, in our experience, often indicates the work of lawyers.

That seems to be the case here, too.

The article, “Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes,” was already the subject of an erratum, available here:

Continue reading Amid a legal dispute, journal downgrades a retraction to an expression of concern

Cell attributes image problems in cloning paper to “minor” errors; sees no impact on conclusions

cell cloningYesterday we reported that Cell was looking into problematic images in a recent paper on human embryonic stem cell cloning. We’ve now heard from the journal about the nature of the inquiry.

Mary Beth O’Leary, a spokeswoman for Cell Press — an Elsevier title — tells us that:

Based on our own initial in-house assessment of the issues raised in PubPeer and in initial discussions with the authors, it seems that there were some minor errors made by the authors when preparing the figures for initial submission.  While we are continuing discussions with the authors, we do not believe these errors impact the scientific findings of the paper in any way. 
Continue reading Cell attributes image problems in cloning paper to “minor” errors; sees no impact on conclusions

Author break prompts retraction of bone protein paper

ejpcoverThe European Journal of Pharmacology has — against its will, it would seem — retracted a 2012 paper by a group of Chinese heart researchers embroiled in a what appears to be a rather messy authorship dispute.

The article, “The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat,”  came from the Institute of Cardiovascular Disease at Tongji Hospital, part of of Huazhong University of Science and Technology.

As the retraction notice states:

Continue reading Author break prompts retraction of bone protein paper

Dodgy figure in cord blood paper prompts Expression of Concern in oncology journal

cmionccoverThe editor of Clinical Medicine Insights: Oncology has issued an Expression of Concern over a 2008 paper by a group of authors in China after identifying “flaws” in one of the figures.

The article, “Exvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cells derived from umbilical cord blood for immunotherapy treatment,” purported to show that:

tumor-specific antigens present on exosomes can be presented by DCs [dendritic cells] derived from unrelated umbilical cord blood to induce tumor specific cytotoxicity and this may represent as a novel immunotherapy for ovarian cancer.

But according to William C. S. Cho, editor of the journal, there’s reason to doubt the conclusions. As the notice explains:
Continue reading Dodgy figure in cord blood paper prompts Expression of Concern in oncology journal

Don’t feel so bad, The Aging Male: It happens to lots of journals

aging maleThe Aging Male (the journal, not the demographic) is retracting a 2013 paper by a group of Chinese researchers who’d published the same work — more or less — in a Chinese title.

The article, “Testosterone therapy improves psychological distress and health-related quality of life in Chinese men with symptomatic late-onset hypogonadism patients,” came from a group at Peking University People’s Hospital, in Beijing.

But as the retraction notice explains: Continue reading Don’t feel so bad, The Aging Male: It happens to lots of journals

A retraction with “serious consequences to wheat production”

pmbrChinese researchers have had a 2012 paper in Plant Molecular Biology Reporter on genetically modified wheat retracted, in a notice that cites fraud.

The article, “Isolation and Functional Characterization of an Antifreeze Protein Gene, TaAFPIII, from Wheat (Triticum aestivum),” came from the same group we wrote about in April 2012 when they retracted a paper from Acta Biochimica et Biophysica Sinica, also about genetically altered wheat.

At the time, the authors said they were pulling the other paper because they were having trouble replicating their findings. That now seems accurate, but not entirely complete.

As the new retraction notice states: Continue reading A retraction with “serious consequences to wheat production”

Not your data: Nursing paper retracted for misuse of findings

nurse education todayWe’re all for research on improving communication and collaboration among colleagues. But we trust that the experts know what they’re doing. You can see where this is going.

The journal Nurse Education Today has retracted a 2012 article, “Interprofessional learning in acute care: Developing a theoretical framework,” by a UK scholar because, how shall we put it, he might need a few lessons in interprofessionalism.

The retraction notice explains it neatly: Continue reading Not your data: Nursing paper retracted for misuse of findings